Fig. 1From: Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre studyFlow diagram describing qHPV vaccine administration in JDM patients and HC before and during the study. JDM: juvenile dermatomyositis; AEFV: adverse events following vaccine; HC: healthy controlsBack to article page